Medical cannabis is a fast-growing field with significant potential and the train has already left the station. “You can’t stop it,” Reut Alfiah, head of the Medical Cannabis Department at ZAG/Sullivan Law Firm told The Jerusalem Post Magazine.
Alfiah recently sat down with the Post to discuss the growth of the cannabis industry and Israel’s distinct advantage in this emerging market.
ZAG/Sullivan is a unique international law firm with offices in Tel Aviv, Boston, New York, Washington, London and China. The firm is a powerhouse when it comes to advising hi-tech and life science startups doing business in Israel and the US. “We have been in the field of medical cannabis for over five years, which may not sound like a lot, but in this relatively new field, it is considered a long time,” she said.
In fact, the firm has a department dedicated exclusively to medical cannabis, which keeps up with the latest regulation, both in Israel and in the US, and provides clients added value – matching investors with companies in the field.
This has positioned the firm as one of the leading, if not the leading, firms in Israel in the field of medical cannabis – a relatively new and developing industry, but one with a long and intricate history.
According to Alfiah, cannabis used to be legal around the world in the 1920s; however, mainly due to politics, it was made illegal and named a “dangerous narcotic.” In fact, there is an international charter that many countries signed on to, agreeing they would not develop the plant.
Read more at jpost.com